Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002317.SZ

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2023: USD 367.70 M

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Revenue is USD 367.70 M for the year ending December 31, 2023, a -5.18% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2022 was USD 387.80 M, a 1.44% change year over year.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2021 was USD 382.29 M, a 31.62% change year over year.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2020 was USD 290.44 M, a -20.10% change year over year.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2019 was USD 363.53 M, a 5.87% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shenzhen Stock Exchange: 002317.SZ

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

CEO	Mr. Yong Hong Chen
IPO Date	Dec. 11, 2009
Location	China
Headquarters	Information Industry Park
Employees	1,732
Sector	Health Care
Industries Pharmaceuticals

Description

Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases. The company was founded in 1979 and is based in Dongguan, China.

Key trends

Past 5 years